Medicis expands with purchase of LipoSonix

June 17, 2008

Scottsdale, Ariz. - Medicis' purchase of LipoSonix, an ultrasound technology used to target fat cells, will launch the company into the international marketplace and the body-contouring business, the East Valley Scottsdale Tribune reports.

Scottsdale, Ariz.

- Medicis' purchase of LipoSonix, an ultrasound technology used to target fat cells, will launch the company into the international marketplace and the body-contouring business, the East Valley Scottsdale Tribune reports.

The company is set to pay $300 million for LipoSonix, with $150 million to be paid up front to acquire the privately-owned company along with its 40 employees and research facilities. Medicis will pay the other $150 million after the U.S. approval process is complete and the technique reaches certain worldwide goals, according to the Tribune.